Xi Chen

Xi Chen

Auto-generated profile, based on publicly available information

Xi Chen

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2008 in Cell
Verified
Journal Article
Closed access
XCXi Chen
Xi Chen
HXHan Xu
Han Xu
PYPing Yuan
Ping Yuan
FFFang Fang
Fang Fang
MHMikael Huss
Mikael Huss
HNHuck-Hui Ng
Huck-Hui Ng

5 March 2006 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
YLYuinhan Hain Loh
Yuinhan Hain Loh
QWQiang Wu
Qiang Wu
JCJoon-Lin Chew
Joon-Lin Chew
VVVinsensius B Vega
Vinsensius B Vega
WZWeiwei Zhang
Weiwei Zhang
HNHuck-Hui Ng
Huck-Hui Ng

19 November 2020 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
XCXi Chen
Xi Chen
JCJuan R. Cubillos-Ruiz
Juan R. Cubillos-Ruiz

28 March 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
FMFabio Martinon
Fabio Martinon
XCXi Chen
Xi Chen
ALAnn-Hwee Lee
Ann-Hwee Lee
LGLaurie H Glimcher
Laurie H Glimcher

23 March 2014 in Nature
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
DIDimitrios Iliopoulos
Dimitrios Iliopoulos
QZQING ZHANG
QING ZHANG
QTQianzi Tang
Qianzi Tang
MGMatthew B. Greenblatt
Matthew B. Greenblatt
LGLaurie H. Glimcher
Laurie H. Glimcher
This study finds that triple-negative breast cancers (TNBC) show an increased basal level of endoplasmic reticulum stress and activation of the XBP1 branch of the unfolded protein response; furthermore, XBP1 promotes tumour formation of TNBC cell lines by interacting with and regulating HIF1α. Laurie Glimcher and colleagues report that in triple-negative breast cancers (TNBCs), the tumour cells show an increased basal level of endoplasmic reticulum stress and activation of the XBP1 branch of the unfolded protein response, a major cellular stress response pathway in the tumour microenvironment. TNBC tumours lack receptors for oestrogen, progesterone and HER2, making them recalcitrant to many drugs through an absence of targets. The authors go on to show that XBP1 promotes tumour formation in TNBC cell lines by interacting with and regulating HIF1α in the absence of hypoxia. This study highlights an important link between two major stress pathways in TNBCs and suggests possible therapeutic interventions for this aggressive form of breast cancer. Cancer cells induce a set of adaptive response pathways to survive in the face of stressors due to inadequate vascularization1. One such adaptive pathway is the unfolded protein (UPR) or endoplasmic reticulum (ER) stress response mediated in part by the ER-localized transmembrane sensor IRE1 (ref. 2) and its substrate XBP1 (ref. 3). Previous studies report UPR activation in various human tumours4,5,6, but the role of XBP1 in cancer progression in mammary epithelial cells is largely unknown. Triple-negative breast cancer (TNBC)—a form of breast cancer in which tumour cells do not express the genes for oestrogen receptor, progesterone receptor and HER2 (also called ERBB2 or NEU)—is a highly aggressive malignancy with limited treatment options7,8. Here we report that XBP1 is activated in TNBC and has a pivotal role in the tumorigenicity and progression of this human breast cancer subtype. In breast cancer cell line models, depletion of XBP1 inhibited tumour growth and tumour relapse and reduced the CD44highCD24low population. Hypoxia-inducing factor 1α (HIF1α) is known to be hyperactivated in TNBCs9,10. Genome-wide mapping of the XBP1 transcriptional regulatory network revealed that XBP1 drives TNBC tumorigenicity by assembling a transcriptional complex with HIF1α that regulates the expression of HIF1α targets via the recruitment of RNA polymerase II. Analysis of independent cohorts of patients with TNBC revealed a specific XBP1 gene expression signature that was highly correlated with HIF1α and hypoxia-driven signatures and that strongly associated with poor prognosis. Our findings reveal a key function for the XBP1 branch of the UPR in TNBC and indicate that targeting this pathway may offer alternative treatment strategies for this aggressive subtype of breast cancer.

1 July 2005 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
JCJoon-Lin Chew
Joon-Lin Chew
YLYuinhan Hain Loh
Yuinhan Hain Loh
WZWensheng Zhang
Wensheng Zhang
XCXi Chen
Xi Chen
WTWai Leong Tam
Wai Leong Tam
HNHuck-Hui Ng
Huck-Hui Ng
Embryonic stem cells (ESCs) are pluripotent cells that can either self-renew or differentiate into many cell types. Oct4 and Sox2 are transcription factors essential to the pluripotent and self-renewing phenotypes of ESCs. Both factors are upstream in the hierarchy of the transcription regulatory network and are partners in regulating several ESC-specific genes. In ESCs, Sox2 is transcriptionally regulated by an enhancer containing a composite sox-oct element that Oct4 and Sox2 bind in a combinatorial interaction. It has previously been shown that Pou5f1, the Oct4 gene, contains a distal enhancer imparting specific expression in both ESCs and preimplantation embryos. Here, we identify a composite sox-oct element within this enhancer and show that it is involved in Pou5f1 transcriptional activity in ESCs. In vitro experiments with ESC nuclear extracts demonstrate that Oct4 and Sox2 interact specifically with this regulatory element. More importantly, by chromatin immunoprecipitation assay, we establish that both Oct4 and Sox2 bind directly to the composite sox-oct elements in both Pou5f1 and Sox2 in living mouse and human ESCs. Specific knockdown of either Oct4 or Sox2 by RNA interference leads to the reduction of both genes9 enhancer activities and endogenous expression levels in addition to ESC differentiation. Our data uncover a positive and potentially self-reinforcing regulatory loop that maintains Pou5f1 and Sox2 expression via the Oct4/Sox2 complex in pluripotent cells.